The Course of Acute Pancreatitis in Patients With Different BMI Groups
Comparison of the Severity and Complications of Acute Pancreatitis in Obese and Non-obese Patients According to the Atlanta and Balthazar Scores
1 other identifier
observational
1,334
1 country
1
Brief Summary
In obese (OB) patients, the presence of an increased inflammatory state in the body due to the increase in abdominal adipose tissue and increase in the frequency of gallstones and lipid levels are expected to increase the development of acute pancreatitis (AP). The effect of obesity on the clinical course of acute pancreatitis has much been attracted the attention of researchers. The aim of this study is to evaluate whether the prevalence and severity of AP, as well as Balthazar tomographic scoring, differs in BMI groups (normal, overweight, obese).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2021
CompletedFirst Submitted
Initial submission to the registry
May 3, 2021
CompletedFirst Posted
Study publicly available on registry
May 26, 2021
CompletedMay 26, 2021
May 1, 2021
6 months
May 3, 2021
May 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The course of acute pancreatitis (mild, moderate, and severe) will be evaluated in patients with different body mass index groups.
The course of acute pancreatitis is defined as mild (no organ insufficiency and local complications), moderate (presence of local complications +/- transient organ insufficiency less than \<48h), and severe (permanent organ insufficiency longer than 48h) according to the revised Atlanta scoring. Body mass index is calculated by dividing the weight of a patient (as a kilogram) by the height (as a square meter). Normal weighted patients form Group 1 (≤24,9 kg/m2), overweighted patients form Group 2 (25-30 kg/m2), and obese patients form Group 3 (≥30,1 kg/m2).
Within a month
Efficacy of acute pancreatitis tomographic scoring (Balthazar) in different body mass index groups
Does the course of acute pancreatitis in the body mass index groups (Group 1, 2, and 3) show parallelism with the tomographic scoring? Whether tomographic score is successful or not in different body mass index groups?
Within a month
Secondary Outcomes (5)
Hospitalization days of the patients according to body mass index groups?
Within a month
Need for intensive care unit hospitalization
Within a month
Did the patient lose his life due to AP?
Within a month
Whether interventional procedures such as endosonography or endoscopic retrograde cholangiopancreatography are required due to the patient's disease
Within a month
How many times has the patient had an acute pancreatitis attack?
Through study completion, an average of 1 year
Study Arms (3)
BMI Group 1
If BMI is less than 24,9 kg/m2
BMI Group 2
If BMI is between 25 - 30 kg/m2
BMI group 3
If BMI is more than 30,1 kg/m2
Eligibility Criteria
Patients with a diagnosis of acute pancreatitis.
You may qualify if:
- Patients with acute pancreatitis diagnosis according to the revised Atlanta criteria.
You may not qualify if:
- Patients who sign a treatment rejection form immediately after admission to the hospital and leave the hospital,
- Psychiatric patients
- Patients with very poor general conditions will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bezmialem Vakif University, Gastroenterology Clinic
Istanbul, 34093, Turkey (Türkiye)
Related Publications (3)
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. doi: 10.1136/gutjnl-2012-302779. Epub 2012 Oct 25.
PMID: 23100216RESULTKhatua B, El-Kurdi B, Singh VP. Obesity and pancreatitis. Curr Opin Gastroenterol. 2017 Sep;33(5):374-382. doi: 10.1097/MOG.0000000000000386.
PMID: 28719397RESULTShin KY, Lee WS, Chung DW, Heo J, Jung MK, Tak WY, Kweon YO, Cho CM. Influence of obesity on the severity and clinical outcome of acute pancreatitis. Gut Liver. 2011 Sep;5(3):335-9. doi: 10.5009/gnl.2011.5.3.335. Epub 2011 Aug 18.
PMID: 21927663RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali̇ Tüzün Ince
Bezmialem Vakif Universitesi
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2021
First Posted
May 26, 2021
Study Start
September 20, 2020
Primary Completion
April 1, 2021
Study Completion
April 30, 2021
Last Updated
May 26, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share